Physician

Doris Hansen, M.D.

According to 2025 Medicare claims, Doris Hansen, M.D. (NPI: 1881958270) practices hematopoietic cell transplantation and cellular therapy in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC (NPI: 1306833595; TIN: 593238640) and primary practice location at 33612-9416.

Hansen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 68 traditional Medicare patients, billed 248 HCPCS/CPT codes, and received $17,574 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 202 prescription claims across 62 beneficiaries totaling $148,435 in drug costs, led by Sirolimus (Sirolimus). Open Payments data shows 35 records totaling $96,525. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $4,277 and ending at $17,574. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,371 and ending at $148,435. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	12	53	$4,277
2020	73	485	$42,506
2021	69	332	$26,760
2022	62	203	$17,551
2023	46	123	$11,878
2024	68	248	$17,574

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	280	$15,371
2016	68	198	$104,472
2017	64	165	$28,245
2018	45	189	$106,450
2019	26	79	$5,469
2020	62	280	$177,585
2021	79	298	$470,343
2022	55	256	$210,686
2023	54	238	$86,128
2024	62	202	$148,435

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	17	17	$144
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	44	95	$108
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	25	69	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	17	31	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sirolimus	Sirolimus	11	195	$2,981
Acyclovir	Acyclovir	43	1,695	$914
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	660	$103
Oxycodone Hcl	Oxycodone Hcl	17	347	$100
Zolpidem Tartrate	Zolpidem Tartrate	11	330	$58

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$79,725	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$16,800	Adaptive Biotechnologies Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Doris Hansen, M.D.?

Tedicare shows public-source Medicare data for Doris Hansen, M.D. (NPI 1881958270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Doris Hansen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Doris Hansen, M.D.?

Doris Hansen, M.D. is linked to H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC (billing NPI 1306833595) in the available physician profile data.

Does Doris Hansen, M.D. have Open Payments data?

Doris Hansen, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.